Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 139
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Albrecht, Matthew A. Masters, Colin L. Ames, David and Foster, Jonathan K. 2016. Impact of Mild Head Injury on Neuropsychological Performance in Healthy Older Adults: Longitudinal Assessment in the AIBL Cohort. Frontiers in Aging Neuroscience, Vol. 8,

    Anderson, Eric D. Wahoske, Michelle Huber, Mary Norton, Derek Li, Zhanhai Koscik, Rebecca L. Umucu, Emre Johnson, Sterling C. Jones, Jana Asthana, Sanjay and Gleason, Carey E. 2016. Cognitive variability—A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol. 4, p. 47.

    Andrews, K. Abigail Frost, Chris Modat, Marc Cardoso, M. Jorge Rowe, Chris C. Villemagne, Victor Fox, Nick C. Ourselin, Sebastien and Schott, Jonathan M. 2016. Acceleration of hippocampal atrophy rates in asymptomatic amyloidosis. Neurobiology of Aging, Vol. 39, p. 99.

    Ashish, Naveen Bhatt, Priya and Toga, Arthur W. 2016. Global Data Sharing in Alzheimer Disease Research. Alzheimer Disease & Associated Disorders, Vol. 30, Issue. 2, p. 160.

    Buckley, Rachel F. Maruff, Paul Ames, David Bourgeat, Pierrick Martins, Ralph N. Masters, Colin L. Rainey-Smith, Stephanie Lautenschlager, Nicola Rowe, Christopher C. Savage, Greg Villemagne, Victor L. and Ellis, Kathryn A. 2016. Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease. Alzheimer's & Dementia, Vol. 12, Issue. 7, p. 796.

    Burnham, Samantha C Bourgeat, Pierrick Doré, Vincent Savage, Greg Brown, Belinda Laws, Simon Maruff, Paul Salvado, Olivier Ames, David Martins, Ralph N Masters, Colin L Rowe, Christopher C and Villemagne, Victor L 2016. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study. The Lancet Neurology, Vol. 15, Issue. 10, p. 1044.

    Crawford, Karen L. Neu, Scott C. and Toga, Arthur W. 2016. The Image and Data Archive at the Laboratory of Neuro Imaging. NeuroImage, Vol. 124, p. 1080.

    Evered, Lisbeth A. Silbert, Brendan S. Scott, David A. Maruff, Paul and Ames, David 2016. Prevalence of Dementia 7.5 Years after Coronary Artery Bypass Graft Surgery. Anesthesiology, Vol. 125, Issue. 1, p. 62.

    Gu, Ben J. Huang, Xin Ou, Amber Rembach, Alan Fowler, Christopher Avula, Pavan K. Horton, Adam Doecke, James D. Villemagne, Victor L. Macaulay, S. Lance Maruff, Paul Fletcher, Erica L. Guymer, Robyn Wiley, James S. and Masters, Colin L. 2016. Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer’s disease. Acta Neuropathologica,

    Gupta, Veer Bala Doecke, James D. Hone, Eugene Pedrini, Steve Laws, Simon M. Thambisetty, Madhav Bush, Ashley I. Rowe, Christopher C. Villemagne, Victor L. Ames, David Masters, Colin L. Macaulay, Stuart Lance Rembach, Alan Rainey-Smith, Stephanie R. and Martins, Ralph N. 2016. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol. 3, p. 18.

    Hare, Dominic J. Faux, Noel G. Roberts, Blaine R. Volitakis, Irene Martins, Ralph N. and Bush, Ashley I. 2016. Lead and manganese levels in serum and erythrocytes in Alzheimer's disease and mild cognitive impairment: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing. Metallomics, Vol. 8, Issue. 6, p. 628.

    Harrington, Karra D. Gould, Emma Lim, Yen Ying Ames, David Pietrzak, Robert H. Rembach, Alan Rainey-Smith, Stephanie Martins, Ralph N. Salvado, Olivier Villemagne, Victor L. Rowe, Christopher C. Masters, Colin L. and Maruff, Paul 2016. Amyloid burden and incident depressive symptoms in cognitively normal older adults. International Journal of Geriatric Psychiatry,

    Heffernan, Amy L. Chidgey, Cameron Peng, Po Masters, Colin L. and Roberts, Blaine R. 2016. The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer’s Disease Cohorts. Journal of Molecular Neuroscience,

    Lim, Yen Ying Laws, Simon M. Villemagne, Victor L. Pietrzak, Robert H. Porter, Tenielle Ames, David Fowler, Christopher Rainey-Smith, Stephanie Snyder, Peter J. Martins, Ralph N. Salvado, Olivier Bourgeat, Pierrick Rowe, Christopher C. Masters, Colin L. and Maruff, Paul 2016. Aβ-related memory decline inAPOEε4 noncarriers. Neurology, Vol. 86, Issue. 17, p. 1635.

    Lim, Yen Ying Snyder, Peter J. Pietrzak, Robert H. Ukiqi, Albulene Villemagne, Victor L. Ames, David Salvado, Olivier Bourgeat, Pierrick Martins, Ralph N. Masters, Colin L. Rowe, Christopher C. and Maruff, Paul 2016. Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol. 2, p. 19.

    Powell, Ronald I. and Copping, Alex G. 2016. Measuring fatigue-related impairment in the workplace. Journal of Engineering, Design and Technology, Vol. 14, Issue. 3, p. 507.

    Ritchie, Craig W Molinuevo, José Luis Truyen, Luc Satlin, Andrew Van der Geyten, Serge and Lovestone, Simon 2016. Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project. The Lancet Psychiatry, Vol. 3, Issue. 2, p. 179.

    Schmidt, M.E. Matthews, D.C. and Staelens, S. 2016. Developing Therapeutics for Alzheimer's Disease.

    Sørensen, Lauge Igel, Christian Liv Hansen, Naja Osler, Merete Lauritzen, Martin Rostrup, Egill and Nielsen, Mads 2016. Early detection of Alzheimer's disease using MRI hippocampal texture. Human Brain Mapping, Vol. 37, Issue. 3, p. 1148.

    Stratford, Anthony Brophy, Lisa Castle, David Harvey, Carol Robertson, Joanne Corlett, Philip Davidson, Larry and Everall, Ian 2016. Embedding a Recovery Orientation into Neuroscience Research: Involving People with a Lived Experience in Research Activity. Psychiatric Quarterly, Vol. 87, Issue. 1, p. 75.


The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

  • Kathryn A Ellis (a1) (a2) (a3), Ashley I Bush (a2) (a4), David Darby (a5) (a6), Daniela De Fazio (a2), Jonathan Foster (a7) (a8) (a9), Peter Hudson (a10), Nicola T. Lautenschlager (a1) (a11), Nat Lenzo (a7) (a8), Ralph N. Martins (a7) (a8), Paul Maruff (a5) (a6), Colin Masters (a2) (a6), Andrew Milner (a12), Kerryn Pike (a2) (a13), Christopher Rowe (a13), Greg Savage (a14), Cassandra Szoeke (a10) (a3), Kevin Taddei (a7) (a8), Victor Villemagne (a13), Michael Woodward (a13) and David Ames (a1) (a3)
  • DOI:
  • Published online: 01 August 2009

Background: The Australian Imaging, Biomarkers and Lifestyle (AIBL) flagship study of aging aimed to recruit 1000 individuals aged over 60 to assist with prospective research into Alzheimer's disease (AD). This paper describes the recruitment of the cohort and gives information about the study methodology, baseline demography, diagnoses, medical comorbidities, medication use, and cognitive function of the participants.

Methods: Volunteers underwent a screening interview, had comprehensive cognitive testing, gave 80 ml of blood, and completed health and lifestyle questionnaires. One quarter of the sample also underwent amyloid PET brain imaging with Pittsburgh compound B (PiB PET) and MRI brain imaging, and a subgroup of 10% had ActiGraph activity monitoring and body composition scanning.

Results: A total of 1166 volunteers were recruited, 54 of whom were excluded from further study due to comorbid disorders which could affect cognition or because of withdrawal of consent. Participants with AD (211) had neuropsychological profiles which were consistent with AD, and were more impaired than participants with mild cognitive impairment (133) or healthy controls (768), who performed within expected norms for age on neuropsychological testing. PiB PET scans were performed on 287 participants, 100 had DEXA scans and 91 participated in ActiGraph monitoring.

Conclusion: The participants comprising the AIBL cohort represent a group of highly motivated and well-characterized individuals who represent a unique resource for the study of AD. They will be reassessed at 18-month intervals in order to determine the predictive utility of various biomarkers, cognitive parameters and lifestyle factors as indicators of AD, and as predictors of future cognitive decline.

Corresponding author
Correspondence should be addressed to: Kathryn A. Ellis, Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne, St. Vincent's Aged Psychiatry Service, St George's Hospital Campus, 283 Cotham Rd, Kew, Victoria 3101, Australia. Phone: +61 3 9389 2919; Fax +61 3 9816 0477. Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

T. L. Brink , J. A. Yesavage , O. Lum , P. Heersema , M. B. Adey and T. L. Rose (1982). Screening tests for geriatric depression. Clinical Gerontologist, 1, 3744.

M. C. Corballis (2009). The evolution and genetics of cerebral asymmetry. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 364, 867879.

R. M. Corbo and R. Scacchi (1999). Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele? Annals of Human Genetics, 63, 301310.

C. L. Craig (2003). International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise, 35, 13811395.

C. P. Ferri (2005). Global prevalence of dementia: a Delphi consensus study. Lancet, 366, 21122117.

M. F. Folstein , S. E. Folstein and P. R. McHugh (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.

L. Glodzik-Sobanska (2007). Subjective memory complaints: presence, severity and future outcome in normal older subjects. Dementia and Geriatric Cognitive Disorders, 24, 177184.

A. Hodge , A. J. Patterson , W. J. Brown , P. Ireland and G. Giles (2000). The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Australian and New Zealand Journal of Public Health, 24, 576583.

C. Jonker , M. I. Geerlings and B. Schmand (2000). Are memory complaints predictive for dementia? A review of clinical and population-based studies. International Journal of Geriatric Psychiatry, 15, 983991.

B. C. Jost and G. T. Grossberg (1996). The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. Journal of the American Geriatrics Society, 44, 10781081.

R. J. Kryscio , F. A. Schmitt , J. C. Salazar , M. S. Mendiondo and W. R. Markesbery (2006). Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology, 66, 828832.

S. Larrieu (2002). Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology, 59, 15941599.

N. T. Lautenschlager (2008). Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA, 300, 10271037.

C. G. Lyketsos and J. Olin (2002). Depression in Alzheimer's disease: overview and treatment. Biological Psychiatry, 52, 243252.

R. N. Martins (1995). ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. Neuroreport, 6, 15131516.

G. McKhann , D. Drachman , M. Folstein , R. Katzman , D. Price and E. M. Stadlan (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939944.

M. S. Mega , J. L. Cummings , T. Fiorello and J. Gornbein (1996). The spectrum of behavioral changes in Alzheimer's disease. Neurology, 46, 130135.

J. C. Morris (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 24122414.

R. C. Petersen , G. E. Smith , S. C. Waring , R. J. Ivnik , E. G. Tangalos and E. Kokmen (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303308.

K. E. Pike (2007). Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain, 130, 28372844.

B. Reisberg and S. Gauthier (2008). Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. International Psychogeriatrics, 20, 116.

R. Rozzini , M. P. Gozzoli , A. Indelicato , F. Lonati and M. Trabucchi (2008). Patterns of antidepressants prescriptions in a large Italian old population. International Journal of Geriatric Psychiatry, 23, 872873.

C. C. Rowe (2007). Imaging beta-amyloid burden in aging and dementia. Neurology, 68, 17181725.

J. Saxton (2000). Normative data on the Boston Naming Test and two equivalent 30-item short forms. Clinical Neuropsychology, 14, 526534.

R. P. Snaith and A. S. Zigmond (1986). The hospital anxiety and depression scale. British Medical Journal, 292, 344.

V. Solfrizzi (2004). Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology, 63, 18821891.

D. Wechsler (1945). A standardised memory scale for clinical use. Journal of Psychology, 19, 8795.

B. Winblad (2004). Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256, 240246.

J. A. Yesavage (1982). Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research, 17, 3749.

A. S. Zigmond and R. P. Snaith (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361370.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *